OR WAIT null SECS
Click here to read the articles and download the PDF
Because of the potential for product shortages at pharmacies, the FDA has not only given industry more time for compliance—but time to catch up on boosting the supply chain’s interoperable efforts.
A crash course on the bubble itself, including therapeutic areas most affected.
Addressing the bottlenecks in cell and gene therapy manufacturing through a well-designed artificial intelligence approach is essential to avoiding data siloes.
July 31, 2024
The latest news for pharma industry insiders.
July 30, 2024
Gallagher’s 2024 US Physical & Emotional Wellbeing Report outlines ways to meeting evolving needs in the workforce.
The agreement focuses on augmenting the patient support experience, including from an adherence perspective.
July 29, 2024
The partnership—which features a $150 million investment—is also centered around vaccine development in the respiratory and immunology space.
A cohort study investigates whether or not the prevalence of these types of illnesses can vary among individuals who are COVID-positive versus negative.
July 26, 2024
The pre-approval pertains to a solid oral dose product that the CDMO will manufacture for a global pharmaceutical company.
Making connections between different datasets is essential to developing impactful medicines and driving more personalized patient care.